09 Feb 2026
Beyond the Pipeline: Investing in the tools and tech powering CGT
CGT investment is expanding beyond therapeutics. Explore why investors are backing the tools, platforms and technologies powering the industry.
Here is the description field content
You can align different bits of text how you want
We can even bold the text too.
Related Videos
-
How clinical data strategy shapes CGT success. Miguel Forte explores the role of geography, operations and trial design in generating meaningful data. -
What makes a biotech company fundable in 2026? Leading investors reveal the science, data, manufacturing and strategy milestones that drive funding decisions. -
The Investment Summit opens with Christiaan Engstrom, Founder of BLPN, sharing perspectives on capital, strategy and the evolving future of advanced therapies investment. -
Biotech funding is evolving. Explore alternative capital models, structured liquidity and new investor types shaping how emerging companies fund innovation.